Pericardial Delivery of Biological Agents: The Next Frontier? - PubMed (original) (raw)

Editorial

Pericardial Delivery of Biological Agents: The Next Frontier?

Alayn Govea et al. JACC Basic Transl Sci. 2017.

No abstract available

Keywords: catheter delivery; pericardial access; tissue engineering.

PubMed Disclaimer

Figures

None

Graphical abstract

References

    1. Benjamin E.J., Blaha M.J., Chiuve S.E. Heart Disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603. -PMC -PubMed
    1. Kamps J.A., Krenning G. Micromanaging cardiac regeneration: targeted delivery of microRNAs for cardiac repair and regeneration. World J Cardiol. 2016;8:163–179. -PMC -PubMed
    1. Peng B., Chen Y., Leong K.W. MicroRNA delivery for regenerative medicine. Adv Drug Deliv Rev. 2015;88:108–122. -PMC -PubMed
    1. Goussetis E., Manginas A., Koutelou M. Intracoronary infusion of CD133+ and CD133−CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells. 2006;24:2279–2283. -PubMed
    1. Teng C.J., Luo J., Chiu R.C.J., Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg. 2006;132:628–632. -PubMed

Publication types

LinkOut - more resources